key: cord-0949792-uxqj5jw1
authors: Wang, Xiang; Wang, Shoujun; Sun, Liangge; Qin, Guijun
title: Prevalence of diabetes mellitus in 2019 novel coronavirus: a Meta-analysis
date: 2020-05-12
journal: Diabetes Res Clin Pract
DOI: 10.1016/j.diabres.2020.108200
sha: 479ab3612c236046bd0f8b627ad3b56f94e9060e
doc_id: 949792
cord_uid: uxqj5jw1

Abstract Background Since December 2019, a new strain ofcoronavirus named 2019 novel coronavirus (2019-nCoV) has been discovered in Wuhan. The prevalence of diabetes mellitus, which is a great public health issue leading to immunity inhibition and anincreased incidenceofinfections, has been increasing over the past ten years. The aim of this research was to systematically assess the prevalence of diabetes mellitus among 2019-nCoV. Methods We searched PubMed, Embase, Web of Science and Medline for observational studies up to February 25, 2020. A random effects model or fixed-effects model was applied to evaluate the pooled prevalence of diabetes mellitus and odds ratio (OR) with 95% confidence interval (CI). Findings In total, nine papers met the eligibility criteria. The pooled prevalence of DM was 9% (95% CI 6%–12%). There was obvious heterogeneity (I2 65%, p=0.004) in the prevalence of DM in these studies. The prevalence of DM in moderate patients with 2019-nCoV was 7% (95% CI 4%–10%). The prevalence of DM in severe patients with 2019-nCoV was 17% (95% CI 13%–21%). The prevalence of DM in severe patients with 2019-nCoV was significantly higher than that in moderate patients with 2019-nCoV (OR 2.49, 95% CI 1.70 to 3.64). Interpretation To our knowledge, this work is the first report showing the prevalence of diabetes mellitus in patients with 2019-nCoV, which is beneficial to prevent the spread of 2019-nCoV in the future.

Since late December 2019, many patients with pneumonia of unclear etiology were reported to be infected with a novel coronavirus, formerly named as 2019 novel coronavirus or 2019-nCoV and recently named as COVID-19 (coronavirus disease 2019) by the World Health Organization (WHO), in Wuhan, Hubei province, China. 1, 2 Epidemiological investigation showed that most of the patients were linked to the Huanan Seafood Wholesale Market. Previous studies have showed evidence for person to person transmission of the 2019-nCoV in family and hospital settings. [3] [4] [5] Clinical features of 2019-nCoV, which appeared to be similar to SARS-CoV leading to high possibility of ICU admission and high mortality, were fever, fatigue, dry cough, shortness of breath, and acute respiratory distress syndrome (ARDS). 6 As of March 8, 2020, 80859 cases were identified, and 3100 death cases were recorded in China. The number of identified cases in other countries were 25208, and 532 death cases were recorded. The number of newly confirmed cases overseas is still growing, especially in South Korea, Italy, Iran, France and Germany. 2019-nCoV outbreak becomes a greater global threat than terrorism. Although the fatal rate of 2019-nCoV was less than SARS-CoV ( 10% mortality) and MERS-CoV (37% mortality), the confirmed cases of 2019-nCoV were higher than SARS-CoV and MERS-CoV 7-12 .

Diabetes mellitus is an important global health issue leading to severe morbidity and mortality. 13 The International Diabetes Federation has anticipated that the number of diabetic patients will increase to 380 million in 2025, and will finally increase to 439 million in 2030. 13 Previous report showed that diabetes mellitus had been linked with an increased risk of infectious disease hospitalisation. 14 Former study demonstrated that the incidence of postoperative pneumonia was higher in T2DM patients than in those without this disease. 15 Another study indicated that the longterm mortality in community-acquired pneumonia among patients with undiagnosed diabetes mellitus was higher than patients without diabetes mellitus. 16 Therefore, the aims of this meta-analysis were to determine the prevalence of diabetes mellitus among 2019-nCoV. 4 

A literature search was performed using PubMed, Embase, Web of Science, and Medline up to 

The inclusion criteria were as follows: (1) 

Two independent investigators independently examined and extracted data from the literature search, with any debate determined by mutual discussion. The following information was extracted from the selected studies: the corresponding author's name, publication year, country of origin, study design, diagnostic criteria of 2019-nCoV, the prevalence of diabetes mellitus.

Meta-analysis was performed using the STATA package version 13.1 (Stata Corporation, College Station, TX, USA) to merge the prevalence of all studies, and determine the pooled prevalence and its 95% confidence interval (CI) using the generic inverse variance method. A χ2-test-based Q statistic test at P<0.05 and I2 > 50% was conducted to assess the between-study heterogeneity. A fixed-effects model was applied ( P≥0.05 or I2≤50%). Otherwise, a random effect model was applied (P<0.05 or I2 > 50%). Analysis of sensitivity was conducted to evaluate the stability of the meta-analysis with the metaninf algorithm in STATA. The publication bias was investigated through a visual inspection of funnel plots, Begg's rank correlation test and Egger's regression test with the meta bias algorithm in STATA. An asymmetric inverted funnel shape or P<0.05 shows the possible existence of publication bias. 5 

We performed literature search process from PubMed, Embase, Web of Science, and Medline. 495 records were identified through the database searching and 3 additional records identified through other sources, 173 records were removed because of duplication. 325 records were screened for eligibility, 274 records were excluded after screening the titles and abstracts. After reviewing the remaining 51 records, we removed 42 records according to the reasons explained in Figure 1 .

Altogether, 9 studies, which were published before Feb 25, 2020, met the inclusion criteria and were assessed in the meta-analysis (Figure 1 ). 6,17-24

The characteristics of the 9 studies were exhibited in Table 1 . All included studies were retrospective in design. The diagnosis of 2019-nCoV was based on World Health Organization interim guidance in 9 studies. All included studies came from Asia (China). A total sample of 2007 patients with 2019-nCoV were included in the analysis. Among the 9 studies, the maximum number of cases was 1099, whereas the minimum was 21. 7 studies involving more than 50 cases and 2 studies involving less than 50 cases among the 9 studies.

The pooled prevalence of DM was 9% (95% CI 6%-12%). There was obvious heterogeneity (I 2 65%, p=0.004) in the prevalence of DM in these studies ( Figure 2 ). During the sensitivity analysis, the omission of any study did not have a significant influence on the combined estimates, which exhibited a relatively low sensitivity ( Figure 6 ). The symmetry of the funnel plot showed the absence of publication bias within studies (Figure 7) . The P values for Begg's test and Egger's test were 0.251 and 0.221, respectively.

The prevalence of DM in severe patients with 2019-nCoV was 17% (95% CI 13%-21%). There was no obvious heterogeneity (I 2 0%, p=0.766) in the prevalence of DM in these studies (Figure 3 ).

The prevalence of DM in severe patients with 2019-nCoV was significantly higher than that in moderate patients with 2019-nCoV (OR 2.49, 95% CI 1.70 to 3.64). There was no obvious heterogeneity (I 2 39%, p=0.146) in these studies (Figure 4 ). 6 

The prevalence of DM in moderate patients with 2019-nCoV was 7% (95% CI 4%-10%). There was obvious heterogeneity (I 2 58.7%, p=0.033) in the prevalence of DM in these studies ( Figure 5 ).

The mean age of severe COVID-19 group was 56.5 years, and the mean age of moderate COVID-19 group was 46.4 years. The mean age of moderate COVID-19 group was significantly younger than the mean age of severe COVID-19 group (-10.09, 95% CI -14.55,-5.63) (Figure 8 ). 7 

Our meta-analysis has collected data from all observational studies on 2019-nCoV patients with diabetes mellitus in the world. The diagnosis of 2019-nCoV was based on World Health Organization interim guidance (by RT-PCR). The pooled prevalence of DM in 2019-nCoV Patients was 9% (95% CI, 6%-12%) in 9 eligible studies comprising a total of 2007 cases. There was obvious heterogeneity (I 2 95%, p=0.004) in the prevalence of DM in these studies partly due to sample size, design ， screening methods and diagnostic method, which was not solved by our sensitivity analyses.

The prevalence of DM is rising due to increased obesity and population ageing. There was a close relationship between diabetes and infection. Previous study showed that patients with DM were susceptible to developing infections with lower (but not upper) respiratory tract infections and urinary tract infections. 25 Another study demonstrated that patients with diabetes were more likely to be admitted to hospital with infection compared with patients without diabetes. 26 Former study showed that infections were more serious in older people with type 2 diabetes. 27 A meta-analysis of 97 prospective cohort studies showed that patients with diabetes have a higher risk of death from all causes compared with patients without diabetes. 28 Previous study demonstrated that the prevalence rates of type 2 diabetes mellitus were 7.3% (95% CI 5.8-8.7%) in 45-54 years age group, 11.0% (95% CI 9.0-13.0%) in the 55-64 years age group in China. 29 Another study showed that the age-standardized prevalence of total diabetes were 9.7% (10.6% among men and 8.8% among women), which was similar with the prevalence of DM in 2019-nCoV Patients (9% ,95% CI 6%-12%) and the overall prevalence of type 2 diabetes mellitus( 9.1%). 29, 30 The prevalence of diabetes were 20.4% in the more than 60 years age group, which was slightly higher than the prevalence of DM in severe patients with 2019-nCoV whose median age were 56.5 years (17%, 95% CI 13%-21%). 30 However, our research has some limitations. First, we did not perform subgroup analysis due to many of the included studies did not divide the participants into different groups for outcome analysis. Second, all the studies in this Meta-analysis were retrospective with obvious heterogeneity, we adopted random-effects in meta-analysis to solve this problem. Third, because our study is the single-arm meta-analysis without a control group, causality is hard to determine. Fourth, because all included studies were retrospective studies, and most of them did not have age groups. We also 8 cannot obtain the data of the age of 2019-nCoV patients with diabetes mellitus from all included studies. We did not perform age adjustment analysis in this study.

In summary, our meta-analysis has demonstrated that diabetes are prevalent in patients with 2019-nCoV, especially in severe patients with 2019-nCoV . By far, this research is the first report showing the prevalence of diabetes mellitus in patients with 2019-nCoV, which is beneficial to inhibit the spread of 2019-nCoV in the future. 

Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle

Coronavirus Infections-More Than Just the Common Cold

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health -The latest 2019 novel coronavirus outbreak in Wuhan, China

Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome

Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group

Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome

Type 2 diabetes and postoperative pneumonia: An observational, population-based study using the Spanish Hospital Discharge Database

Undiagnosed Diabetes Mellitus in Community-Acquired Pneumonia: A Prospective Cohort Study

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan

Clinical Characteristics of Coronavirus Disease 2019 in China

Clinical features and progression of acute respiratory distress syndrome in coronavirus disease

COVID-19 in a Designated Infectious Diseases 13

HospitalOutside Hubei Province,China. medRxiv preprint

Clinical and immunologic features in severe and moderate forms of Coronavirus Disease

Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus

Diabetes mellitus and infection: an evaluation of hospital utilization and management costs in the United States

New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records

Diabetes mellitus, fasting glucose, and risk of cause-specific death

Prevalence of type 2 diabetes mellitus among inland residents in China (2000-2014): A meta-analysis

Prevalence of diabetes among men and women in China

The authors would like to thank Ms. Chunhuan Ma for her technical assistance. 10 Authors' contributions Xiang Wang had roles in the study design, data collection, data analysis, data interpretation, literature search, and writing of the manuscript. Shoujun Wang, Liangge Sun, and Guijun Qin had roles in data collection, data analysis. All authors reviewed and approved the final version of the manuscript.